The arrival of Retatrutide in the UK is generating significant buzz within the weight loss community. This innovative dual medication – targeting both GLP-1 and GIP – promises a potentially new solution to addressing excess weight . Currently , options have been restricted for many, and Retatrutide represents a hopeful prospect for patients see